Rhein Reduces Fat Weight indb/dbMouse and Prevents Diet-Induced Obesity in C57Bl/6 Mouse through the Inhibition of PPARγSignaling
Author(s) -
Yu Zhang,
Shengjie Fan,
Na Hu,
Ming Gu,
Chunxiao Chu,
Yiming Li,
Xiong Lu,
Cheng Huang
Publication year - 2012
Publication title -
ppar research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.164
H-Index - 49
eISSN - 1687-4765
pISSN - 1687-4757
DOI - 10.1155/2012/374936
Subject(s) - peroxisome proliferator activated receptor , medicine , endocrinology , obesity , chemistry , algorithm , receptor , computer science
Rheum palmatum has been used most frequently in the weight-reducing formulae in traditional Chinese medicine. However, the components of Rheum palmatum that play the antiobesity role are still uncertain. Here, we tested the weight-reducing effect of two major Rheum palmatum compounds on db / db mouse. We found that rhein (100 mg kg −1 day −1 ), but not emodin, reduced the fat weight in db / db mouse. Using diet-induced obese (DIO) C57BL/6 mice, we identified that rhein blocked high-fat diet-induced obesity, decreased fat mass and the size of white and brown adipocytes, and lowered serum cholesterol, LDL cholesterol, and fasting blood glucose levels in the mice. To elucidate the underlying mechanisms, we used reporter assay and gene expression analysis and found that rhein inhibited peroxisome proliferator-activated receptor γ (PPAR γ ) transactivity and the expression of its target genes, suggesting that rhein may act as a PPAR γ antagonist. Our data indicate that rhein may be a promising choice for antiobesity therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom